Advertisement

Der Pathologe

, Volume 25, Issue 5, pp 362–374 | Cite as

Immunhistochemische Darstellung von Lymphgefäßen mit D2–40 in der diagnostischen Pathologie

Originalien

Zusammenfassung

Mit D2–40 ist ein Antikörper verfügbar, der Lymphgefäßendothelien des Menschen verlässlich markiert. Wir haben eine orientierende Studie an verschiedenen pathologischen und nichtpathologischen Geweben durchgeführt, um herauszufinden, ob und welche anderen Zellen D2–40 exprimieren.

Durchgängig werden normale und reaktive Lymphgefäße sowie Lymphgefäßtumoren markiert. Auch ein Teil der Angiosarkome und das Kaposi-Sarkom sind D2–40-positiv.

Positiv reagierende nichtendothelialen Zellen: Mesothelien, follikuläre dendritische Retikulumzellen, interstitielle Zellen von Cajal, einzelne Epithelien der Epidermis und einzelner Hautanhangsgebilde sowie Myoepithelien (z. B. Mamma), basale Epithelien (z. B. Prostata) und verschiedene mesenchymale Zellen.

Positiv reagierende Tumoren: myofibroblastische Tumoren, der gastrointestinale Stromatumor, Mesotheliome, der Adenomatoidtumor, traumatische Neurome, Seminome, das Seminoma in situ und andere Hodentumoren, zweimal ein Karzinom, ein pleomorphes Adenom und das Sarkom der follikulären dendritischen Retikulumzellen.

Trotz des relativ breiten Reaktionsspektrums ist D2–40 der nach unserer Einsicht derzeit am besten geeignete und zudem kommerziell erhältliche Antikörper zur Darstellung normaler, reaktiver und neoplastischer Lymphgefäßendothelien.

Schlüsselwörter

D2–40 Lymphgefäßendothelien Lymphknotensinus Mesothelien GIST 

Immunohistochemical identification of lymph vessels with D2–40 in diagnostic pathology

Abstract

D2–40 is an antibody that reliably detects human lymphatic endothelial cells. Because little is known about the extent to which other cells are stained, we have investigated this question in various tissues.

Normal, reactive and neoplastic lymphatics (including lymphangiomas and Stewart-Treves syndrome) were stained by D2–40. Published findings indicate that some angiosarcomas and Kaposi are positive. Staining was also found in the following non-endothelial cells: mesothelial cells, follicular dendritic reticulum cells, Cajal cells, a few epithelial cells in the dermis, myoepithelial cells (e. g. breast), and basal cells (e. g. prostata), various mesenchymal cells. The following tumours were reactive: myofibroblastic tumours, gastrointestinal stromal tumour, mesothelioma, adenomatoid tumour, traumatic neuroma, seminoma, seminoma in situ and other testicular tumours, pleomorphic adenoma (one of two tumours positive), and follicular dendritic reticulum cell sarcoma.

Despite this relatively broad spectrum of reactivity, we consider D2–40 to be the best commercially available antibody for the delineation of normal, reactive and neoplastic lymphatic endothelial cells.

Keywords

D2-40 Lymphatic endothelial cells Lymph node sinus Mesothelial cells GIST 

Notes

Danksagung

Ich danke bei dieser Gelegenheit in besonderem Maße meiner MTA Frau Anne Adam für ihr langjähriges und das übliche Maß weit überschreitende Engagement. In diesen Dank eingebunden sind zahlreiche weitere Personen, meine Sekretärin Frau Dorothea Biesinger, Frau Adelheid Mall, Frau Friederike Müller, Frau Carola Weihing und Frau Brigitte Bachmann mit ihren zahlreichen Mitarbeitern/innen.

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Literatur

  1. 1.
    Adegboyega PA, Mifflin RC, DiMari JF et al. (2002) Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. Arch Pathol Lab Med. 125:829–836Google Scholar
  2. 2.
    Baumal R, Bailey D, Giwercman A et al. (1989) A novel maturation marker for human Sertoli cells. Intern J Andrology 12:354–359Google Scholar
  3. 3.
    Blagosklonova O, Joanne C, Roux C et al. (2002) Absence of anti-Müllerian hormone (AMH) and M2A immunoreactivities in Sertoli cell-only syndrome and maturation arrest with and without AZF microdelections. Hum Reprod 17:2062–2065CrossRefPubMedGoogle Scholar
  4. 4.
    Breiteneder-Geleff S, Soleiman A, Kowalski ZH et al. (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries. Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385–394PubMedGoogle Scholar
  5. 5.
    Breiteneder-Geleff S, Soleiman A, Horvat R et al. (1999) Podoplanin—ein spezifischer Marker für Lymphgefäßendothelien wird in Angiosarkomen exprimiert. Verh Dtsch Ges Path 83:270–275Google Scholar
  6. 6.
    Erovic BM, Neuchrist C, Kandutsch S et al. (2003) CD9 expression on lymphatic vessels in head and neck mucosa. Mod Pathol 16:1028–1034CrossRefPubMedGoogle Scholar
  7. 7.
    Fogt F, Pascha TL, Zhang PJ et al. (2004) Proliferation of D2–40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory disease. Int J Mol Med 13:211–214PubMedGoogle Scholar
  8. 8.
    Fogt F, Zimmerman RL, Ross HM et al. (2004) Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2–40. Oncol Rep 11:47–50PubMedGoogle Scholar
  9. 9.
    Franke FE, Steger K, Marks A et al. (2004) Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas. J Cutan Pathol, in pressGoogle Scholar
  10. 10.
    Giorgadze T, Zhang PJ, Pasha T et al. (2004) Lymphatic vessel density is significantly increased in melanoma (Abstract 380). Mod Pathol 17:93AGoogle Scholar
  11. 11.
    Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580PubMedGoogle Scholar
  12. 12.
    Ji R-C, Qu P, Kato S (2003) Application of a new 5’-Nase mononuclear antibody specific for lymphatic endothelial cells. Lab Invest 83:1681–1683CrossRefPubMedGoogle Scholar
  13. 13.
    Kahn HJ, Bailey D, Marks A (2002) Monoclonal antibody D2–40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and subset of angiosarcomas. Mod Pathol 15:434–440CrossRefPubMedGoogle Scholar
  14. 14.
    Kahn HJ, Marks A (2002) A new monoclonal antibody, D2–40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255–1257PubMedGoogle Scholar
  15. 15.
    Kaiserling E (1997) Morphologie der Lymphangiome. LymphForsch 2:59–67Google Scholar
  16. 16.
    Kaiserling E (2001) Zur Histologie des Lipödems. In: Strößenreuther RHK (Hrsg) Lipödem und Cellulitis sowie andere Erkrankungen des Fettgewebes. Viavital, Köln, S 90–99Google Scholar
  17. 17.
    Kaiserling E (2002) Morphologische Alterationen beim chronischen Lymphödem. In: Földi M, Kubik S (Hrsg) Lehrbuch der Lymphologie. Urban & Fischer, München Jena, S 350–378Google Scholar
  18. 18.
    Kaiserling E (2003) Morphological changes in chronic lymphedema. In: Földi M, Földi E, Kubik S (eds) Textbook of lymphology. Urban & Fischer, München Jena, pp 322–370Google Scholar
  19. 19.
    Kaiserling E (2003) Metastasis of malignant tumors In: Földi M, Földi E, Kubik S (eds) Textbook of lymphology. Urban & Fischer, München Jena, pp 456–564Google Scholar
  20. 20.
    Kaiserling E (2004) Cellular reaction in acute and chronic lymphedema. XIX. International Congress of Lymphology, September 1–6 September 2003. Freiburg. Prog Lymphology, in pressGoogle Scholar
  21. 21.
    Kaiserling E, Kröber S (1994) Lymphatic amyloidosis, a previously unrecognized form of amyloid deposition in generalized amyloidosis. Histopathology 24:215–221PubMedGoogle Scholar
  22. 22.
    Kaiserling E, Kröber S, Geleff S (2003) Lymphatic vessels in the colonic mucosa in ulcerative colitis. Lymphology 36:52–61PubMedGoogle Scholar
  23. 23.
    Kaiserling E, Xiao, J-C, Adam A, Ruck P (1998) Der Lymphknotensinus als Leitungssystem. Morphologische und immunhistochemische Befunde. In: Kaiserling E, Kröber SM, Ruck P (Hrsg) Lymphologica, Kongressband 1998, Gesellschaft Deutschsprachiger Lymphologen. Kargerer Kommunikation, Bonn, S 37–43Google Scholar
  24. 24.
    Kato S, Itonaga I, Ji RC, Miura M (1996) Enzyme triple staining for differentiation of lymphatics from venous and arterial capillaries. Lymphology 29:15–19PubMedGoogle Scholar
  25. 25.
    Kröber SM, Marx A, Aebert H et al. (2004) Sarcoma of follicular dendritic cells in the dorsal mediastinum. Human Pathol 35:259–263CrossRefGoogle Scholar
  26. 26.
    Lymboussaki A, Partanen TA, Olofsson B et al. (1998) Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 153:395–403PubMedGoogle Scholar
  27. 27.
    Marks A, Sutherland DR, Bailey D et al. (1999) Characerization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumors. Br J Cancer 80:569–578CrossRefPubMedGoogle Scholar
  28. 28.
    Mentzel T, Partanen TA, Kutzner H (1999) Hobnail hemangioma („targetoid hemosiderotic hemangioma“): clinicopatholical and immunohistochemical analysis of 62 cases. J Cutan Pathol 26:279–286PubMedGoogle Scholar
  29. 29.
    Paavonen K, Puolakkainen P, Jussila L et al. (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156:1499–1504Google Scholar
  30. 30.
    Paavonen K, Mandelin J, Partanen T et al. (2002) Vascular endothelial growth factor C and D and their VEGF-2 and 3 receptor in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol 29:39–45PubMedGoogle Scholar
  31. 31.
    Pantanowitz L, Antonioli DA, Pinkus GS et al. (2004) Inflammatory fibroid polyps of the gastointestinal tract. Evidence for a dendritic cell origin. Am J Surg Pathol 28:107–114PubMedGoogle Scholar
  32. 32.
    Pantanowitz L, Tahan SR, Dezube BJ, Pinkus GS (2004) Dendritic, endothelial and lymphatic cell markers in Kaposi’s sarcoma (Abstract 400). Mod Pathol 17:97AGoogle Scholar
  33. 33.
    Prevo R, Banerji S, Ferguson DJ et al. (2001) Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 276:19420–19430Google Scholar
  34. 34.
    Preyer S, Kaiserling E, Heinle H et al. (1995) Benign supraclavicular tumorous lymhangiectasia—a new disease? Lymphology 28:118–125PubMedGoogle Scholar
  35. 35.
    Rozenbajgier C, Ruck P, Jenss H, Kaiserling E (1992) Filiforme polyposis. A case report describing clinical, morphological and immunohistochemical findings. Clin Invest 70:520–528Google Scholar
  36. 36.
    Ruck P, Xiao J-Ch, Kaiserling E (1995) Immunoreactivity of sinusoids in hepatoblastoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelium-associated antigens, including CD34. Histopathology 26:451–455PubMedGoogle Scholar
  37. 37.
    Sharpe RM, McKinnell C, Kivlin C, Fisher JS (2002) Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood (Review). Reproduction 125:769–784CrossRefGoogle Scholar
  38. 38.
    Steger K, Rey R, Louis F et al. (1999) Revision of the diffentiated phenotype and maturation block in Sertoli cells in pathological human testis. Hum Reprod 14:163–143CrossRefGoogle Scholar
  39. 39.
    Wacker HH, Radzun HJ, Mielke V, Parwaresch MR (1987) Selective recognition of follicular dendritic cells (dendritic reticulum cells) by a new monoclonal antibody Ki-M4R in vivo and in vitro. J Leukocyte Biol 41:70–77PubMedGoogle Scholar
  40. 40.
    Wigle JT, Harvey N, Detmar M et al. (2002) An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. Embo J 21:1505–1513CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Institut für Pathologie, UniversitätsklinikumEberhard-Karls-Universität Tübingen

Personalised recommendations